Dalpicilib-Enhanced Vs. Standard Endocrine Therapy in ER+ HER2- Early Breast Cancer
Clinical trial NCT06637150 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06637150
- Sponsor
- Fudan University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-01
- Primary completion
- 2030-09-30
- Enrollment
- 1388
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.